Nurcan DEDEOĞLU

Dr. Nurcan DEDEOĞLU


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
VDViviana DeLuca
Viviana DeLuca
SISemra Isik
Semra Isik
HYHatice Yildirim
Hatice Yildirim
FKFeray Tura Köçkar
Feray Tura Köçkar
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 July 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
VLViviana De Luca
Viviana De Luca
SISemra Isik
Semra Isik
HYHatice Yildirim
Hatice Yildirim
FKFeray Kockar
Feray Kockar
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

27 January 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DVDaniela Vullo
Daniela Vullo
SPSonia Del Prete
Sonia Del Prete
VLViviana De Luca
Viviana De Luca
VCVincenzo Carginale
Vincenzo Carginale
MFMarta Ferraroni
Marta Ferraroni
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

22 February 2014 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
MAMikail Arslan
Mikail Arslan
MEMahmut Erzengin
Mahmut Erzengin

5 January 2026 in Afyon Kocatepe University Journal of Sciences and Engineering
Verified
Journal Article
Closed access
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
ADAyşenur Demir
Ayşenur Demir
CYCem Yamali
Cem Yamali
SISemra Işık
Semra Işık
Lactoperoxidase (LPO E.C. 1.11.1.7) is a glycoprotein belonging to the class of oxidoreductases and constitutes a notable member of the peroxidase enzyme family. The biological significance of LPO is attributed to its role as a natural defense system against microbial infection. In the current study, to examine the inhibitory effects of 8 different polyfluoro-substituted pyrazoline-type primary sulfonamide derivative compounds on LPO enzyme activity, LPO enzyme was extracted from buffalo milk and purified using affinity gel, resulting in a 2212.45-fold purification, a 19.31 % yield, and a specific activity of 4955.9 EU/mg. Ki values for the active inhibitors were determined to be between 1.02±0.53-6.67±2.94 µM, while their IC50 values were in the range of 0.144±0.03-0.798±0.07 µM. The IC50 value and Ki values for the most effective inhibitor, Compound 3, were calculated as 0.144±0.03 and 6.06±4.06 µM, respectively, and it was found that this compound inhibited LPO enzyme activity non-competitively.

16 April 2024
Verified
Book
Open access
PDF file
SSSaja Said
Saja Said
GÖGül Özbey
Gül Özbey
BABeril Altun
Beril Altun
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
MSMehtap Tugrak Sakarya
Mehtap Tugrak Sakarya
BKBerna Öztürk Karagöz
Berna Öztürk Karagöz
Pharmacogenetics of Antidepressants: Overview of Dosing Strategies in Major Depressive Disorder Saja SAİD Gül ÖZBEY Therapeutic Use of Cannabinoids: Clinical Overview and Recent Updates Beril ALTUN The Xanthine Oxidase Inhibitory Activities of Natural-Based Compounds Targeting Gout Nurcan DEDEOĞLU The Relationship of Dementia and Diabetes Mehtap TUGRAK SAKARYA Rational Use of Drugs Dilan ÖZMEN ÖZGÜN Endocrine Therapy in Breast Cancer: Recent Advances in the Drugs Used Dilek AKSOY Strategies to Increase Solubility and Bioavailability of Drugs İrem ÇİNAR Emrah ÖZAKAR Rukiye SEVİNÇ ÖZAKAR Vesıcular Drug Delivery Systems Muhammet Enes ÖZMUTLU Rukiye SEVİNÇ ÖZAKAR Emrah ÖZAKAR Definition of Pharmacovigilance and Its Historical Development in the World and Türkiye Berna ÖZTÜRK KARAGÖZ